Case report: Rare variants in the MTRR gene, 66GG and 524TT cause hyperhomocysteinemia and folic acid deficiency linked to schizophrenia
Open Access
- 12 July 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1353308
Abstract
We present an adult patient with schizophrenia who was later found to have hyperhomocysteinemia, a condition that increases the risk of several diseases, due to a deficiency in folic acid. Although folic acid supplementation quickly normalized the hyperhomocysteinemia and folic acid levels, it did not significantly improve the overall mental and cognitive health. Genotype analysis was performed and the patient was found to have two pathogenic variants in the MTRR gene, 66GG and 524TT, which encodes for methionine synthase reductase (MSR), an enzyme crucial for homocysteine metabolism. The results can shed light on the reasons behind the patient’s hyperhomocysteinemia and folic acid deficiency. Hyperhomocysteinemia confers an increased risk of several diseases. Indeed, the patient has neurodevelopment and cardiovascular health problems for decades. Given the rarity of the condition and the nonspecific nature of the symptoms, the detection of hyperhomocysteinemia or MSR deficiency can often be delayed or overlooked. Considering the potential irreversible and detrimental consequences of prolonged hyperhomocysteinemia and folic acid deficiency that our patient is likely experiencing, we suggest that clinicians be vigilant for associated signs when they encounter adolescents exhibiting psychotic symptoms, especially those with additional physical symptoms and a history of resistance to treatment.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 109-2314-B-039-040)
This publication has 39 references indexed in Scilit:
- Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the personEPMA Journal, 2021
- The N-terminus of MTRR plays a role in MTR reactivation cycle beyond electron transferBioorganic Chemistry, 2020
- Neuro-fuzzy model of homocysteine metabolismJournal of Genetics, 2017
- Contribution of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms to Negative Symptoms in SchizophreniaBiological Psychiatry, 2008
- The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifidaJournal of Molecular Medicine, 2006
- American Journal of Medical Genetics2006
- Schizophrenia as a Complex TraitArchives of General Psychiatry, 2003
- A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease riskJournal of Molecular Medicine, 2001
- A Common Variant in Methionine Synthase Reductase Combined with Low Cobalamin (Vitamin B12) Increases Risk for Spina BifidaMolecular Genetics and Metabolism, 1999
- A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme ActivityMolecular Genetics and Metabolism, 1998